drugset / Trial / NCT00287924

High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma

NCT00287924 ↗

Phase 2 Unknown 29 enrolled Children's Cancer and Leukaemia Group
Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as methotrexate, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well high-dose methotrexate works in treating young patients with residual ependymoma.

Timeline

Start
2005-03
Primary completion
2010-03
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Methotrexate Small molecule — Intravenous